6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Sleep Disorders and Psychiatric Implications
The connection between disrupted sleep and mental illness is far more than coincidental. Researchers now recognize sleep disorders and psychiatric implications as intricately linked, with insomnia, hypersomnia, and parasomnias contributing to and resulting from conditions like depression, bipolar disorder, and PTSD. Sleep disturbances can precede a psychiatric episode or worsen ongoing symptoms, creating a cyclical pattern that demands clinical attention. Cognitive Behavioral Therapy for Insomnia (CBT-I), melatonin regulation, light exposure therapy, and digital sleep hygiene tools are gaining prominence in mental health care. Moreover, innovations in polysomnography and wearable sleep trackers allow for more accurate diagnosis. Addressing sleep quality is increasingly seen as a critical step in long-term psychiatric recovery and prevention.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States